Revolution in der Diabetesdiagnostik dank -omics - Biomarker mittels Metabolomics

Kilian Wörmann; Alesia Walker; Franco Moritz; Sara Forcisi; Dimitrios Tziotis; Marianna Lucio; Silke S. Heinzmann; Jerzy Adamski; Rainer Lehmann; Hans Ulrich Häring; Philippe Schmitt-Kopplin

doi:10.1055/s-0032-1320054

Revolution in der Diabetesdiagnostik dank -omics - Biomarker mittels Metabolomics

Translated title of the contribution: Revolution in diabetes diagnostics - Metabolomics for discovering biomarkers

Kilian Wörmann
, Alesia Walker
, Franco Moritz
, Sara Forcisi
, Dimitrios Tziotis
, Marianna Lucio
, Silke S. Heinzmann
, Jerzy Adamski
, Rainer Lehmann
, Hans Ulrich Häring
, Philippe Schmitt-Kopplin

Helmholtz Zentrum München German Research Center for Environmental Health
Mitglied im Deutschen Zentrum für Diabetesforschung (DZD
Universitätsklinikum Tübingen
University of Tübingen

Research output: Contribution to journal › Review article › peer-review

Abstract

In diabetes research Metabolomics is a new approach for discovering unknown diagnostic biomarkers for early detection and monitoring of the disease. Also new insights into the pathogenetic evolution of the metabolic disorder and its late complications are interesting. Since metabolites are intermediates and end product of all metabolic pathways they offer a high chance to identify new biomarkers or metabolic patterns. For that purpose either the number of detected metabolites is maximized or few are quantified in diverse biological samples like body fluids, tissues and cell cultures. Besides a general introduction to metabolomic research also a short summary of current metabolomics analysis in diabetic research will be presented in this review.

Translated title of the contribution	Revolution in diabetes diagnostics - Metabolomics for discovering biomarkers
Original language	German
Pages (from-to)	129-133
Number of pages	5
Journal	Diabetes Aktuell
Volume	10
Issue number	3
DOIs	https://doi.org/10.1055/s-0032-1320054
State	Published - 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1055/s-0032-1320054

Cite this

@article{42eb6b28c3bc4d0a99b34f7e8149d7eb,

title = "Revolution in der Diabetesdiagnostik dank -omics - Biomarker mittels Metabolomics",

abstract = "In diabetes research Metabolomics is a new approach for discovering unknown diagnostic biomarkers for early detection and monitoring of the disease. Also new insights into the pathogenetic evolution of the metabolic disorder and its late complications are interesting. Since metabolites are intermediates and end product of all metabolic pathways they offer a high chance to identify new biomarkers or metabolic patterns. For that purpose either the number of detected metabolites is maximized or few are quantified in diverse biological samples like body fluids, tissues and cell cultures. Besides a general introduction to metabolomic research also a short summary of current metabolomics analysis in diabetic research will be presented in this review.",

keywords = "diabetes diagnostic, metabolic profiling, metabolite, metabonomics",

author = "Kilian W{\"o}rmann and Alesia Walker and Franco Moritz and Sara Forcisi and Dimitrios Tziotis and Marianna Lucio and Heinzmann, \{Silke S.\} and Jerzy Adamski and Rainer Lehmann and H{\"a}ring, \{Hans Ulrich\} and Philippe Schmitt-Kopplin",

year = "2012",

doi = "10.1055/s-0032-1320054",

language = "Deutsch",

volume = "10",

pages = "129--133",

journal = "Diabetes Aktuell",

issn = "1861-6089",

publisher = "Georg Thieme Verlag",

number = "3",

}

TY - JOUR

T1 - Revolution in der Diabetesdiagnostik dank -omics - Biomarker mittels Metabolomics

AU - Wörmann, Kilian

AU - Walker, Alesia

AU - Moritz, Franco

AU - Forcisi, Sara

AU - Tziotis, Dimitrios

AU - Lucio, Marianna

AU - Heinzmann, Silke S.

AU - Adamski, Jerzy

AU - Lehmann, Rainer

AU - Häring, Hans Ulrich

AU - Schmitt-Kopplin, Philippe

PY - 2012

Y1 - 2012

N2 - In diabetes research Metabolomics is a new approach for discovering unknown diagnostic biomarkers for early detection and monitoring of the disease. Also new insights into the pathogenetic evolution of the metabolic disorder and its late complications are interesting. Since metabolites are intermediates and end product of all metabolic pathways they offer a high chance to identify new biomarkers or metabolic patterns. For that purpose either the number of detected metabolites is maximized or few are quantified in diverse biological samples like body fluids, tissues and cell cultures. Besides a general introduction to metabolomic research also a short summary of current metabolomics analysis in diabetic research will be presented in this review.

AB - In diabetes research Metabolomics is a new approach for discovering unknown diagnostic biomarkers for early detection and monitoring of the disease. Also new insights into the pathogenetic evolution of the metabolic disorder and its late complications are interesting. Since metabolites are intermediates and end product of all metabolic pathways they offer a high chance to identify new biomarkers or metabolic patterns. For that purpose either the number of detected metabolites is maximized or few are quantified in diverse biological samples like body fluids, tissues and cell cultures. Besides a general introduction to metabolomic research also a short summary of current metabolomics analysis in diabetic research will be presented in this review.

KW - diabetes diagnostic

KW - metabolic profiling

KW - metabolite

KW - metabonomics

UR - https://www.scopus.com/pages/publications/84862282538

U2 - 10.1055/s-0032-1320054

DO - 10.1055/s-0032-1320054

M3 - Übersichtsartikel

AN - SCOPUS:84862282538

SN - 1861-6089

VL - 10

SP - 129

EP - 133

JO - Diabetes Aktuell

JF - Diabetes Aktuell

IS - 3

ER -

Revolution in der Diabetesdiagnostik dank -omics - Biomarker mittels Metabolomics

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this